Solifenacin (for overactive bladder) — Patient Guide

Solifenacin is a medicine used to treat symptoms of overactive bladder, a condition that can cause urinary urgency, frequencyurge incontinence (a sudden, hard-to-delay leakage). It belongs to a group of medicines known as antimuscarinics.

This guide explains how solifenacin works, how it is typically taken, key safety information, and what to expect in everyday use—tailored for users in the United Kingdom.

Quick product information

What is overactive bladder?

Overactive bladder is a common bladder condition. People with it may experience:

• Urgency: a sudden need to pass urine
• Frequency: passing urine more often than usual
• Urge incontinence: leaking after a sudden urge

Solifenacin helps reduce unwanted bladder muscle contractions, making it easier to delay urination and improving bladder control.

Mechanism of action (how solifenacin works)

Solifenacin works by blocking muscarinic receptors in the bladder. These receptors are involved in the bladder’s contraction and urge signals.

By inhibiting these pathways, solifenacin:

• Calms involuntary bladder contractions
• Increases bladder capacity (reducing urgency)
• Helps reduce frequency and leakage in people with overactive bladder

Pharmacokinetics (how the body processes solifenacin)

Pharmacokinetics describes how a medicine is absorbed, distributed, metabolised, and eliminated. Key points for solifenacin include:

• Absorption: Solifenacin is absorbed after oral use. Peak levels occur roughly within the day after taking the dose (timing can vary).
• Distribution: It distributes through the body and primarily acts on the urinary tract.
• Metabolism: Solifenacin is metabolised mainly in the liver by enzymes including CYP3A4.
• Elimination: It is cleared from the body through a combination of renal (kidney) and non-renal routes.

Because liver metabolism plays a role, some medicines that affect liver enzymes can change solifenacin levels. Kidney and liver function can also influence how safe it is to use and the appropriate dose.

Typical use and indications

Solifenacin is indicated for the treatment of overactive bladder syndrome characterised by:

• Urgency
• Urge incontinence
• Increased urinary frequency

It is usually considered when bladder training and lifestyle changes alone are insufficient, or alongside them, depending on your clinical assessment.

How and when to take solifenacin

Typical dosing (general guidance)

Usual adult dosing for overactive bladder is commonly 5 mg once daily, sometimes increased to 10 mg once daily based on response and tolerability. Your exact dose should follow the product packaging and healthcare advice you receive.

Timing

• Once daily: take it at the same time each day to help build a routine.
• Swallow whole: tablets should generally be swallowed whole with water and not crushed or chewed. (Always follow the leaflet instructions for your specific product.)
• If you miss a dose: take it when you remember unless it is close to the next scheduled dose. Do not take a double dose.

Expect gradual improvement. Many people notice changes within days, but the most noticeable effect can take several weeks. If symptoms persist, it may require a review of dose or treatment plan.

Food interactions

Solifenacin can be taken with or without food. Food is not generally expected to significantly impair the medicine’s effect for most users. However, individual tolerability may vary (for example, if nausea occurs).

Practical tip: If you experience stomach discomfort, taking your dose with a meal or after food may help.

Alcohol interactions

Solifenacin is not typically labelled with a direct “no alcohol” rule, but alcohol can worsen urinary symptoms and can increase certain side effects such as:

• Dizziness or light-headedness
• Drowsiness in some individuals
• Dehydration (which may contribute to constipation and dry mouth)

For best comfort and symptom control, consider limiting alcohol and maintain good hydration unless advised otherwise.

Medicine interactions (important)

Solifenacin can interact with other medicines—mainly by affecting how it is broken down in the body, or by adding to antimuscarinic effects. Always check your full medication list with a healthcare professional or pharmacist.

Examples of medicines that may be relevant

• Strong CYP3A4 inhibitors (can increase solifenacin levels): e.g. some antifungal medicines and certain antibiotics (exact examples depend on product and local guidance).
• Antimuscarinic medicines (may increase side effects such as dry mouth, constipation, blurred vision) if used at the same time.
• Medicines that reduce gut movement or increase risk of constipation (interaction via overall effect on the digestive system).
• Other urinary medicines or medicines used for bladder control (combining treatments should be assessed carefully).

If you take medicines that affect the liver or have a strong anticholinergic burden, your prescriber/pharmacist may choose a different option or adjust the solifenacin dose and monitoring.

Safety profile and side effects

Like all medicines, solifenacin can cause side effects. Many are related to its antimuscarinic action and may include effects on the mouth, eyes, bowel, bladder, and sometimes the nervous system.

Common side effects

• Dry mouth
• Constipation
• Blurred vision or difficulty focusing
• Difficulty passing urine (urinary retention), especially in people with predisposition
• Indigestion or stomach discomfort
• Headache or dizziness (less common)

Serious side effects (seek urgent advice)

Stop and seek urgent medical advice if you experience signs of a serious allergic reaction (such as swelling of the face/lips, severe rash, or breathing difficulties), or if you develop:

• Severe trouble urinating or inability to pass urine
• Severe constipation, abdominal pain, or vomiting
• Confusion, severe drowsiness, or agitation (more likely in older adults or with high anticholinergic load)
• Marked worsening of eye symptoms (especially if you have narrow-angle glaucoma)

Who should take extra care?

Solifenacin may not be suitable or may need closer monitoring if you have:

• Narrow-angle glaucoma
• Gastrointestinal obstruction or severe constipation
• Myasthenia gravis (a muscle weakness condition)
• Severe reduction in bladder emptying or urinary retention risk (including significant prostate enlargement in men)
• Moderate or severe liver impairment or severe kidney impairment (dose and suitability may differ)

Practical use tips (to get the best results)

• Track your symptoms for a few weeks: note times of urgency, frequency of urination, and any leakage episodes. This helps you and your clinician evaluate whether the dose is right.
• Manage dry mouth: sip water regularly, choose sugar-free chewing gum or lozenges, and maintain good oral hygiene. If dryness is troublesome, speak to a healthcare professional.
• Prevent constipation: aim for adequate fluid intake, fibre-rich foods, and regular activity. If constipation occurs, consider discussing fibre supplements or an appropriate laxative with a pharmacist.
• Be cautious with driving or operating machinery if you experience blurred vision or dizziness.
• Hydration and bladder training: even while taking solifenacin, behavioural strategies such as scheduled toilet trips and bladder training can improve outcomes.
• Review medicines regularly: if you start new medicines, ask your pharmacist whether they affect solifenacin or increase antimuscarinic side effects.

Dose adjustments and special populations

Suitability and dosing may be influenced by age, kidney function, liver function, and other medical conditions. Extra caution is recommended in older adults because antimuscarinic side effects can be more noticeable and because some adverse effects may be harder to recognise early.

If you have reduced kidney or liver function, your clinician/pharmacist may choose a lower dose or consider an alternative.

Alternative options for overactive bladder

If solifenacin is not tolerated or not effective, there are other options. These may include:

Other medicines

• Other antimuscarinics (different side-effect profiles): e.g. oxybutynin, tolterodine, fesoterodine, trospium.
• Beta-3 agonists (different mechanism): e.g. mirabegron (not an antimuscarinic).

Non-medicine approaches

• Bladder training and scheduled toileting
• Pelvic floor muscle exercises (often helpful for urge incontinence)
• Lifestyle changes such as reducing bladder irritants (some people find caffeine or fizzy drinks worsen symptoms)

A healthcare professional can help decide the most suitable approach based on symptom pattern, medical history, and side effects.

UK market and legal context (what to expect)

In the United Kingdom, treatment for overactive bladder is commonly provided through NHS services and private consultations, depending on availability and individual circumstances. Medicines used for bladder symptoms may be supplied through pharmacy routes that comply with UK medicines legislation and pharmacy standards.

Online pharmacies in the UK typically provide products under regulatory requirements, including identity checks and assessment of suitability via appropriate clinical pathways.

If you are buying solifenacin online, ensure the product is a genuine medicine from a UK-registered supply chain and that packaging includes the correct strength and patient information leaflet.

Recent guidance and evolving practice (UK)

Guidance for managing overactive bladder in the UK continues to emphasise:

• Stepwise management (starting with behavioural approaches, then medicines when needed)
• Individualised choice based on symptom burden and side-effect risk
• Caution with antimuscarinic medicines in older adults due to the risk of dry mouth, constipation, blurred vision, urinary retention, and potential cognitive effects in some people.
• Reviewing benefit regularly to decide whether to continue, adjust dose, or switch treatments

If you have not had improvement after an adequate trial, it may be appropriate to discuss switching to another option.

Delivery and availability (online pharmacy)

Availability of solifenacin can vary depending on stock levels and the exact strength/formulation (for example, 5 mg vs 10 mg). Many UK pharmacies offer:

• Standard and express delivery options (depending on provider and location)
• Packaging in secure, tamper-evident materials to protect tablets during transit
• Tracking updates for dispatched orders

Delivery times can be influenced by weekends, public holidays, and stock availability. When ordering online, check the estimated delivery window displayed at checkout.

Safety checklist before you start

Before taking solifenacin, consider discussing suitability with a pharmacist/clinician if any of the following apply:

• You have glaucoma, especially narrow-angle
• You have a history of urinary retention or severe difficulty emptying your bladder
• You suffer from constipation or bowel obstruction
• You have liver disease or kidney impairment
• You take other medicines with antimuscarinic effects
• You are pregnant, breastfeeding, or planning pregnancy (discuss individually)

FAQ — Solifenacin

1) How quickly will solifenacin work?

Some people notice improvements within the first few days, but the full benefit can take several weeks. If there is little or no improvement after a reasonable trial, talk to a healthcare professional about next steps.

2) Can I take solifenacin with food?

Yes. Solifenacin is generally taken with or without food. If it upsets your stomach, taking it after food may help.

3) What should I do if I miss a dose?

Take it when you remember unless it’s close to the next dose. Do not take a double dose to make up for a missed tablet.

4) What side effects are most common?

Common side effects include dry mouth, constipation, and sometimes blurred vision. If side effects are persistent or severe, seek advice promptly.

5) Is it safe to drive?

If solifenacin causes blurred vision, dizziness, or drowsiness, avoid driving or hazardous activities until you feel safe.

6) Can I drink alcohol while taking solifenacin?

Alcohol is not always strictly prohibited, but it may worsen dehydration and symptoms and could increase side effects such as dizziness. Consider moderating intake and staying well hydrated.

7) Who should avoid solifenacin or take extra care?

Extra caution is needed for people with glaucoma, urinary retention, significant constipation, certain bowel problems, and moderate/severe kidney or liver impairment. Always check with a healthcare professional.

8) Are there alternatives if solifenacin doesn’t suit me?

Yes. Options can include another antimuscarinic, a beta-3 agonist, or non-drug approaches such as bladder training and pelvic floor exercises. Your best choice depends on your symptoms and side-effect tolerance.

9) Can solifenacin interact with other medicines?

Yes. Solifenacin can interact with medicines that affect liver enzymes (including CYP3A4) and with other medicines that have antimuscarinic effects. Always review your medication list with a pharmacist.

10) How long should I take it?

The duration depends on response and tolerability. If symptoms improve, your clinician may recommend continuing for long-term symptom control, with periodic review. If no improvement occurs, a review of treatment is usually advised.

When to seek medical help

Seek urgent medical advice if you suspect an overdose or experience severe side effects, such as inability to pass urine, severe constipation with abdominal pain, or signs of a serious allergic reaction.

If you have new or worsening symptoms, consult a healthcare professional for personalised guidance.

Note: This information is intended to support patient understanding. Always read the patient information leaflet provided with your specific solifenacin product and follow the advice of a qualified healthcare professional.